Pfizer and Allergan scrap US$160b "inversion" deal
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[BENGALURU] US drugmaker Pfizer Inc and Ireland-based Allergan Plc formally announced that they were scrapping their US$160 billion merger, marking a big win for President Barack Obama who has been pushing to curb tax-slashing "inversion" deals.
The announcement followed the unveiling of new US Treasury rules on Monday aimed at curbing such deals. The merger would have allowed New York-based Pfizer to cut its tax bill by redomiciling to Ireland, where tax rates are lower.
A source familiar with the matter told Reuters on Tuesday that the deal would be terminated.
Pfizer said on Wednesday it had agreed to pay Allergan US$150 million for reimbursement of expenses associated with the deal.
REUTERS
Share with us your feedback on BT's products and services
TRENDING NOW
StarHub hands Ensign InfoSecurity control back to Temasek in S$115 million deal, books S$200 million gain
Singaporeans can now buy record amount of yen per Singdollar
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
Keppel DC Reit posts 13.2% higher Q1 DPU of S$0.02833 on strong portfolio performance
